StockData
Elevance Health, Inc. logo

Elevance Health, Inc.

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3014% below fair value
$413.60−6.47 (-1.54%)

Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –

Elevance Health Total Net Incurred Medical Claims by Quarter

Total Net Incurred Medical Claims ($M)

QuarterlyAnnual

Elevance Health Total Net Incurred Medical Claims: $36,765M in Q3 2026, down 1.0% from a year earlier.

Latest, Q3 2026
36,765
Period ended Sep 30, 2026
Change on a year earlier
-1.0%
37,132 in Q3 2025
History
43 quarters
Since Q1 2016
Sources
2
Documents cited below

Where the Q3 2026 figure comes from

“us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1 (2026-09-30): 107,313,000,000.00”

Calculated from reported figures: quarter = year-to-date − previous year-to-date (cash flow / footnote)

Source: ELV 10-Q (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1) ↗

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal Net Incurred Medical Claims ($M)Year on yearSource
Q3 2026Sep 30, 202636,765-1.0%ELV 10-Q (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1) ↗
Q2 2026Jun 30, 202635,995+0.7%ELV 10-Q (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1) ↗
Q1 2026Mar 31, 202634,553+0.8%ELV 10-Q (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1) ↗
Q4 2025Dec 31, 202537,119+14.1%ELV 10-K (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1) ↗
Q3 2025Sep 30, 202537,132+15.9%ELV 10-Q (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1) ↗
Q2 2025Jun 30, 202535,737+20.8%ELV 10-Q (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1) ↗
Q1 2025Mar 31, 202534,288+16.2%ELV 10-Q (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1) ↗
Q4 2024Dec 31, 202432,534+6.6%ELV 10-K (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1) ↗
Q3 2024Sep 30, 202432,027+8.4%ELV 10-Q (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1) ↗
Q2 2024Jun 30, 202429,575-3.0%ELV 10-Q (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1) ↗
Q1 2024Mar 31, 202429,503-0.6%ELV 10-Q (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1) ↗
Q4 2023Dec 31, 202330,511+4.2%ELV 10-K (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1) ↗
Q3 2023Sep 30, 202329,538+3.6%ELV 10-Q (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1) ↗
Q2 2023Jun 30, 202330,495+10.4%ELV 10-Q (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1) ↗
Q1 2023Mar 31, 202329,683+9.4%ELV 10-Q (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1) ↗
Q4 2022Dec 31, 202229,269+10.6%ELV 10-K (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1) ↗

Breakdown

What makes up total Net Incurred Medical Claims

Cite this data

StockData. (2026). Elevance Health Total Net Incurred Medical Claims ($M), quarterly Q1 2016–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/mcp-incurred-total-net

See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.